Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1123232812 | 11232328 | 12 | F | 201504 | 20160920 | 20150701 | 20160923 | EXP | GB-ROCHE-1592679 | ROCHE | 72.20 | YR | F | Y | 0.00000 | 20160923 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1123232812 | 11232328 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | |||||||
| 1123232812 | 11232328 | 2 | SS | Trastuzumab | TRASTUZUMAB | 1 | Subcutaneous | 103792 | 600 | MG | SOLUTION FOR INJECTION | Q3W | |||||||
| 1123232812 | 11232328 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 0 | 140 | MG | Q3W | ||||||||
| 1123232812 | 11232328 | 4 | C | CHLORPHENIRAMINE. | CHLORPHENIRAMINE | 1 | Intravenous (not otherwise specified) | 0 | 10 | MG | Q3W | ||||||||
| 1123232812 | 11232328 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | TABLET | QD | |||||||
| 1123232812 | 11232328 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 60 | MG | TABLET | QD | |||||||
| 1123232812 | 11232328 | 7 | C | DIPYRIDAMOLE. | DIPYRIDAMOLE | 1 | Oral | 0 | 25 | MG | TABLET | BID | |||||||
| 1123232812 | 11232328 | 8 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 0 | 8 | MG | TABLET | BID | |||||||
| 1123232812 | 11232328 | 9 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 1123232812 | 11232328 | 10 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 0 | 30 | MG | TABLET | ||||||||
| 1123232812 | 11232328 | 11 | C | LOPERAMIDE | LOPERAMIDE | 1 | Oral | AS REQUIRED | 0 | 2 | MG | TABLET | |||||||
| 1123232812 | 11232328 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 6.6 | MG | Q3W | ||||||||
| 1123232812 | 11232328 | 13 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 8 | MG | TABLET | ||||||||
| 1123232812 | 11232328 | 14 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 3.3 | MG | Q3W | ||||||||
| 1123232812 | 11232328 | 15 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 2 | MG | TABLET | ||||||||
| 1123232812 | 11232328 | 16 | C | Granisetron | GRANISETRON | 1 | Intravenous (not otherwise specified) | 0 | 1 | MG | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1123232812 | 11232328 | 1 | HER-2 positive breast cancer |
| 1123232812 | 11232328 | 2 | HER-2 positive breast cancer |
| 1123232812 | 11232328 | 3 | HER-2 positive breast cancer |
| 1123232812 | 11232328 | 11 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1123232812 | 11232328 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1123232812 | 11232328 | Abdominal pain | |
| 1123232812 | 11232328 | Blood potassium decreased | |
| 1123232812 | 11232328 | Body temperature increased | |
| 1123232812 | 11232328 | Constipation | |
| 1123232812 | 11232328 | Dehydration | |
| 1123232812 | 11232328 | Diarrhoea | |
| 1123232812 | 11232328 | Febrile neutropenia | |
| 1123232812 | 11232328 | Melaena | |
| 1123232812 | 11232328 | Nausea | |
| 1123232812 | 11232328 | Neutropenia | |
| 1123232812 | 11232328 | Neutropenic sepsis | |
| 1123232812 | 11232328 | Oesophagitis | |
| 1123232812 | 11232328 | Pain | |
| 1123232812 | 11232328 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1123232812 | 11232328 | 1 | 20150326 | 20150728 | 0 | |
| 1123232812 | 11232328 | 2 | 20150326 | 20150728 | 0 | |
| 1123232812 | 11232328 | 3 | 20150326 | 20150707 | 0 | |
| 1123232812 | 11232328 | 4 | 201504 | 0 | ||
| 1123232812 | 11232328 | 5 | 2001 | 0 | ||
| 1123232812 | 11232328 | 6 | 2001 | 0 | ||
| 1123232812 | 11232328 | 7 | 2001 | 0 | ||
| 1123232812 | 11232328 | 8 | 20150326 | 0 | ||
| 1123232812 | 11232328 | 9 | 20150326 | 0 | ||
| 1123232812 | 11232328 | 10 | 201504 | 0 | ||
| 1123232812 | 11232328 | 11 | 201504 | 0 | ||
| 1123232812 | 11232328 | 12 | 201504 | 0 | ||
| 1123232812 | 11232328 | 13 | 20150414 | 20150708 | 0 | |
| 1123232812 | 11232328 | 14 | 20150812 | 20150818 | 0 | |
| 1123232812 | 11232328 | 15 | 20150815 | 20150828 | 0 | |
| 1123232812 | 11232328 | 16 | 201504 | 0 |